Anterogen.Co.,Ltd. Market Cap

Anterogen.Co.,Ltd. has a market cap or net worth of 375.23 billion as of January 16, 2026. Its market cap has increased by 125.49% in one year.

Market Cap

375.23B

Enterprise Value

331.14B

Revenue

7.32B

Ranking

n/a

PE Ratio

n/a

Stock Price

37,500.00

Market Cap Chart

Since February 15, 2016, Anterogen.Co.,Ltd.'s market cap has increased from 291.82B to 375.23B, an increase of 28.58%. That is a compound annual growth rate of 2.57%.

Market Cap History

Date	Market Cap	% Change
Jan 16, 2026	389.24B	-16.97%
Dec 30, 2025	468.79B	155.02%
Dec 30, 2024	183.83B	10.53%
Dec 28, 2023	166.31B	16.26%
Dec 29, 2022	143.05B	-76.39%
Dec 30, 2021	605.82B	6.94%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Feb 15, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	88.92T
Celltrion	45.18T
ALTEOGEN	26.53T
ABL Bio	10.89T
SK Biopharmaceuticals	9.26T
Yuhan	7.91T
HLB Co., Ltd.	6.83T
Sam Chun Dang Pharm.	6.43T

Market Cap Rankings